Volume 18, Issue 12, Pages (December 2011)

Slides:



Advertisements
Similar presentations
Volume 18, Issue 11, Pages (November 2011)
Advertisements

Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 11, Issue 8, Pages (August 2004)
Volume 12, Issue 10, Pages (October 2005)
Volume 17, Issue 1, Pages (January 2010)
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 21, Issue 3, Pages (March 2014)
Kinetochores: NDC80 Toes the Line
Finding the Missing Code of RNA Recognition by PUF Proteins
Volume 19, Issue 10, Pages (October 2012)
Structure-Based Design of Covalent Siah Inhibitors
Volume 17, Issue 11, Pages (November 2010)
Volume 21, Issue 6, Pages (March 2006)
Volume 18, Issue 11, Pages (November 2011)
Volume 36, Issue 4, Pages (November 2009)
Volume 14, Issue 5, Pages (May 2007)
Volume 22, Issue 3, Pages (March 2015)
Volume 130, Issue 6, Pages (September 2007)
Volume 17, Issue 4, Pages (April 2009)
Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity
Volume 12, Issue 9, Pages (September 2005)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 18, Issue 11, Pages (November 2011)
Volume 21, Issue 5, Pages (May 2014)
Volume 23, Issue 8, Pages (August 2016)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Rules for Nuclear Localization Sequence Recognition by Karyopherinβ2
Volume 17, Issue 1, Pages (January 2010)
Volume 18, Issue 7, Pages (July 2011)
Volume 20, Issue 1, Pages 9-19 (October 2005)
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Volume 23, Issue 5, Pages (May 2015)
Volume 18, Issue 7, Pages (July 2011)
Charlene Depry, Sohum Mehta, Ruojing Li, Jin Zhang  Chemistry & Biology 
Volume 19, Issue 8, Pages (August 2012)
Sachin Surade, Tom L. Blundell  Chemistry & Biology 
Volume 20, Issue 1, Pages (January 2013)
Structural Basis of EZH2 Recognition by EED
Volume 22, Issue 9, Pages (September 2015)
Volume 18, Issue 4, Pages (April 2011)
Kevin M. Marks, Michael Rosinov, Garry P. Nolan  Chemistry & Biology 
Volume 91, Issue 5, Pages (November 1997)
Volume 18, Issue 1, Pages (January 2011)
A Drug-Drug Interaction Crystallizes a New Entry Point into the UPR
Volume 20, Issue 2, Pages (February 2013)
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 21, Issue 5, Pages (May 2014)
Volume 17, Issue 11, Pages (November 2010)
Volume 12, Issue 11, Pages (November 2005)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Richard D. Perrins, Giuseppe Cecere, Ian Paterson, Gerard Marriott 
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Volume 91, Issue 5, Pages (November 1997)
Volume 18, Issue 4, Pages (April 2011)
Volume 12, Issue 6, Pages (June 2005)
Volume 21, Issue 10, Pages (October 2014)
Jue Wang, Jia-Wei Wu, Zhi-Xin Wang  Structure 
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
Volume 19, Issue 8, Pages (August 2011)
Volume 17, Issue 10, Pages (October 2009)
Volume 23, Issue 4, Pages (April 2015)
Volume 18, Issue 7, Pages (July 2011)
Volume 21, Issue 5, Pages (May 2013)
Volume 18, Issue 11, Pages (November 2011)
Volume 13, Issue 11, Pages (November 2006)
A Plug Release Mechanism for Membrane Permeation by MLKL
Features of Selective Kinase Inhibitors
Fine Details of IGF-1R Activation, Inhibition, and Asymmetry Determined by Associated Hydrogen /Deuterium-Exchange and Peptide Mass Mapping  Damian Houde,
Binding Specificity of Retinal Analogs to Photoactivated Visual Pigments Suggest Mechanism for Fine-Tuning GPCR-Ligand Interactions  Sundaramoorthy Srinivasan,
Volume 21, Issue 6, Pages (June 2013)
Presentation transcript:

Volume 18, Issue 12, Pages 1631-1639 (December 2011) Targeting the Proangiogenic VEGF-VEGFR Protein-Protein Interface with Drug-like Compounds by In Silico and In Vitro Screening  Benoit Gautier, Maria A. Miteva, Victor Goncalves, Florent Huguenot, Pascale Coric, Serge Bouaziz, Bili Seijo, Jean-François Gaucher, Isabelle Broutin, Christiane Garbay, Aurelien Lesnard, Sylvain Rault, Nicolas Inguimbert, Bruno O. Villoutreix, Michel Vidal  Chemistry & Biology  Volume 18, Issue 12, Pages 1631-1639 (December 2011) DOI: 10.1016/j.chembiol.2011.10.016 Copyright © 2011 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2011 18, 1631-1639DOI: (10. 1016/j. chembiol. 2011 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 The VEGF-VEGFR-1 Complex Schematic diagram illustrating our approach for blocking VEGF signaling by inhibition of VEGF-VEGFR PPI. The approach followed in this work does not intend to inhibit the tyrosine kinase site but aims at the inhibition of a PPI (red arrows) through design of a ligand binding to the D2 domain by combining in silico-in vitro screening experiments. See also Figure S1. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Structural Analysis of the VEGF-VEGFR-1 Complex Left view shows the crystal structure (Wiesmann et al., 1997) of residues 8–109 of VEGF (VEGF8–109 cartoon diagram) in complex with VEGFR-1 D2 domain (shown here in solid-surface representation: yellow, hydrophobic/aromatic; red, oxygen atom and/or negatively charged; blue, nitrogen atom and/or positively charged). A probe-mapping algorithm (Jain, 2003) was used to analyze the interface area (green sphere highlights regions where carbon atoms can bind with reasonable affinity, blue spheres represent nitrogen atoms, and red spheres, carbonyl groups). Three subpockets, A, B, and C, could be identified and are shown as dashed circles. Right-top dashed square illustrates the deformability in the screening region that was assessed with the DFprot server (Garzon et al., 2007). Color-coded deformation values are projected on a mesh representation of the receptor. In the screening region, areas of Y139 and F172 are expected to be flexible (deformable regions are in red; regions somewhat more flexible are in light blue and green), whereas the interface itself, color coded in dark blue, appears relatively rigid. Right-bottom dashed square shows the overall search zone investigated during the docking computations that is delineated by the dashed lines and forms a relatively large triangle. See also Figure S2. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 3 General Structure of the (3-Carboxy-2-Ureido)Thiophen Series In Compound 4321: R1, Ethyl; R1′, Benzyl. See also Figure S3, and Tables S1 and S2. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 4 WaterLOGSY Experiments Structure of the compound 4321, 1D spectra, and WaterLOGSY spectra of the compound in the absence of the VEGFR-1 D2 (A and C) and in the presence of the domain VEGFR-1 D2 (B and D). The positive signal of the compound on spectra D demonstrates an interaction between the small molecule and the VEGFR-1 D2. Some peaks arising from VEGFR-1 D2 are visible, in particular in the 1D spectra (B) around 3 ppm. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 5 Compound 4321 Inhibits VEGF-Induced Phosphorylation of Both VEGFR-1 and VEGFR-2 Starved HUVECs were incubated with compound 4321 at the indicated concentration over a period of 1 hr and then stimulated by VEGF165 50 ng/ml during 5 min, cells were lysed, and cellular extracts were submitted to specific antibodies. Western blots were performed with anti-phospho-VEGFR-1 (P-VEGFR-1) and anti-VEGFR-1 (A) and anti-phospho-VEGFR-2 (P-VEGFR-2) and anti-VEGFR-2 (B), and in both cases anti-α-tubulin was used as control (data result from three independent experiments). Relative optical density of the bands in arbitrary units is represented for P-VEGFR-1 (C) and P-VEGFR-2 (D) both reported to the α-tubulin control. All results are expressed as mean ± SD. Control without VEGF is considered as 100%. ∗p < 0.0001 versus the group without VEGF165; ∗∗p < 0.0001 and ∗∗∗p < 0.001 versus the group with VEGF165. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 6 Effect of Compound 4321 on Tubule Formation Network (A) HUVECs were seeded on Matrigel with or without 50 ng/ml of VEGF165 in the presence or the absence of compound 4321 at the indicated concentrations. Tube-like structures were visualized 4 hr later. (B) Tube-like structures formation was quantified by the number of branching points. The control without VEGF165 is considered as 100%, and results are expressed as the mean ± SD. ∗p < 0.0001 versus the group without VEGF165; ∗∗p < 0.0001 versus the group with VEGF165. See Figure S4. Chemistry & Biology 2011 18, 1631-1639DOI: (10.1016/j.chembiol.2011.10.016) Copyright © 2011 Elsevier Ltd Terms and Conditions